Exonate is Drug Discovery in United Kingdom that focus on Provider business. Founded in 2013. They cover business area such as Provider, biopharmaceutical service, patient, retinal vascular disease, vision loss, lead, program molecule, wet Age-relate Macular Degeneration, action, pathological blood vessel, pathological Vascular Endothelial Growth Factor, beneficial, non-pathological VEGF, doctor, novel therapy, wet age-relate macular degeneration.
2013
( 11 years old in 2024 )
Provider
-
WTL Moorfield Road
Duxford
Cambridge CB22 4PS
England, United Kingdom
Private
Providerbiopharmaceutical servicepatientretinal vascular diseasevision lossleadprogram moleculewet Age-relate Macular Degenerationactionpathological blood vesselpathological Vascular Endothelial Growth Factorbeneficial, non-pathological VEGFdoctornovel therapywet age-relate macular degeneration
* We use standard office opening hours in near Exonate's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Exonate is Drug Discovery business from United Kingdom that founded in 2013 (11 years old in 2024), Exonate business is focusing on Provider.
Exonate headquarter office and corporate office address is located in WTL Moorfield Road Duxford Cambridge CB22 4PS England, United Kingdom.
Exonate was founded in United Kingdom.
In 2024, Exonate is currently focus on Provider sector.
Above is snippet of Google Trends for "Provider" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Exonate, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
